These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. TREM2 Variants and Neurodegenerative Diseases: A Systematic Review and Meta-Analysis. Zhou SL; Tan CC; Hou XH; Cao XP; Tan L; Yu JT J Alzheimers Dis; 2019; 68(3):1171-1184. PubMed ID: 30883352 [TBL] [Abstract][Full Text] [Related]
6. TREM2 R47H variant and risk of essential tremor: a cross-sectional international multicenter study. Ortega-Cubero S; Lorenzo-Betancor O; Lorenzo E; Agúndez JA; Jiménez-Jiménez FJ; Ross OA; Wurster I; Mielke C; Lin JJ; Coria F; Clarimon J; Ezquerra M; Brighina L; Annesi G; Alonso-Navarro H; García-Martin E; Gironell A; Marti MJ; Yueh KC; Wszolek ZK; Sharma M; Berg D; Krüger R; Pastor MA; Pastor P Parkinsonism Relat Disord; 2015 Mar; 21(3):306-9. PubMed ID: 25585992 [TBL] [Abstract][Full Text] [Related]
7. Lack of association between TREM2 rs75932628 variant and amyotrophic lateral sclerosis. Siokas V; Aloizou AM; Liampas I; Tsouris Z; Mentis AA; Nasios G; Papadimitriou D; Bogdanos DP; Hadjigeorgiou GM; Dardiotis E Mol Biol Rep; 2021 Mar; 48(3):2601-2610. PubMed ID: 33826063 [TBL] [Abstract][Full Text] [Related]
8. Assessing the role of the TREM2 p.R47H variant as a risk factor for Alzheimer's disease and frontotemporal dementia. Ruiz A; Dols-Icardo O; Bullido MJ; Pastor P; Rodríguez-Rodríguez E; López de Munain A; de Pancorbo MM; Pérez-Tur J; Alvarez V; Antonell A; López-Arrieta J; Hernández I; Tárraga L; Boada M; Lleó A; Blesa R; Frank-García A; Sastre I; Razquin C; Ortega-Cubero S; Lorenzo E; Sánchez-Juan P; Combarros O; Moreno F; Gorostidi A; Elcoroaristizabal X; Baquero M; Coto E; Sánchez-Valle R; Clarimón J; Neurobiol Aging; 2014 Feb; 35(2):444.e1-4. PubMed ID: 24041969 [TBL] [Abstract][Full Text] [Related]
9. Differential role of triggering receptors expressed on myeloid cells 2 R47H in 3 neurodegenerative diseases based on a systematic review and meta-analysis. Zhang B; Li R; Zhang Y; Gao X Medicine (Baltimore); 2020 Jan; 99(5):e18921. PubMed ID: 32000403 [TBL] [Abstract][Full Text] [Related]
10. Microglial activation, tau and amyloid deposition in TREM2 p.R47H carriers and mild cognitive impairment patients: a multi-modal/multi-tracer PET/MRI imaging study with influenza vaccine immune challenge. Cousins O; Schubert JJ; Chandra A; Veronese M; Valkimadi P; Creese B; Khan Z; Arathimos R; Hampshire A; Rosenzweig I; Ballard C; Corbett A; Aasland D; Velayudhan L; O'Neill M; Collier D; Awais R; Sander K; Årstad E; Howes O; Turkheimer F; Hodges A J Neuroinflammation; 2023 Nov; 20(1):272. PubMed ID: 37990275 [TBL] [Abstract][Full Text] [Related]
11. Assessment of TREM2 rs75932628 association with amyotrophic lateral sclerosis in a Chinese population. Chen X; Chen Y; Wei Q; Guo X; Cao B; Ou R; Zhao B; Shang HF J Neurol Sci; 2015 Aug; 355(1-2):193-5. PubMed ID: 26026943 [TBL] [Abstract][Full Text] [Related]
12. R47H TREM2 variant increases risk of typical early-onset Alzheimer's disease but not of prion or frontotemporal dementia. Slattery CF; Beck JA; Harper L; Adamson G; Abdi Z; Uphill J; Campbell T; Druyeh R; Mahoney CJ; Rohrer JD; Kenny J; Lowe J; Leung KK; Barnes J; Clegg SL; Blair M; Nicholas JM; Guerreiro RJ; Rowe JB; Ponto C; Zerr I; Kretzschmar H; Gambetti P; Crutch SJ; Warren JD; Rossor MN; Fox NC; Collinge J; Schott JM; Mead S Alzheimers Dement; 2014 Nov; 10(6):602-608.e4. PubMed ID: 25160042 [TBL] [Abstract][Full Text] [Related]
13. Frontobasal gray matter loss is associated with the TREM2 p.R47H variant. Luis EO; Ortega-Cubero S; Lamet I; Razquin C; Cruchaga C; Benitez BA; Lorenzo E; Irigoyen J; ; Pastor MA; Pastor P Neurobiol Aging; 2014 Dec; 35(12):2681-2690. PubMed ID: 25027412 [TBL] [Abstract][Full Text] [Related]
14. The rs75932628 and rs2234253 polymorphisms of the TREM2 gene were associated with susceptibility to frontotemporal lobar degeneration in Caucasian populations. Su WH; Shi ZH; Liu SL; Wang XD; Liu S; Ji Y Ann Hum Genet; 2018 Jul; 82(4):177-185. PubMed ID: 29322490 [TBL] [Abstract][Full Text] [Related]
15. TREM2 is associated with the risk of Alzheimer's disease in Spanish population. Benitez BA; Cooper B; Pastor P; Jin SC; Lorenzo E; Cervantes S; Cruchaga C Neurobiol Aging; 2013 Jun; 34(6):1711.e15-7. PubMed ID: 23391427 [TBL] [Abstract][Full Text] [Related]
16. Association study of TREM2 polymorphism rs75932628 with leucoaraiosis or Parkinson's disease in the Han Chinese population. Li Z; Zhong L; Gu L; Huang W; Shi X; Zhang X; An X; Lin Q; Tzeng CM BMJ Open; 2016 Jan; 6(1):e009499. PubMed ID: 26758262 [TBL] [Abstract][Full Text] [Related]
17. Genetic analysis of TREM2 variants in Chinese Han patients with sporadic Parkinson's disease. Tan T; Song Z; Yuan L; Xiong W; Deng X; Ni B; Chen Y; Deng H Neurosci Lett; 2016 Jan; 612():189-192. PubMed ID: 26704436 [TBL] [Abstract][Full Text] [Related]
18. The rare TREM2 R47H variant exerts only a modest effect on Alzheimer disease risk. Hooli BV; Parrado AR; Mullin K; Yip WK; Liu T; Roehr JT; Qiao D; Jessen F; Peters O; Becker T; Ramirez A; Lange C; Bertram L; Tanzi RE Neurology; 2014 Oct; 83(15):1353-8. PubMed ID: 25186855 [TBL] [Abstract][Full Text] [Related]
19. Variants in triggering receptor expressed on myeloid cells 2 are associated with both behavioral variant frontotemporal lobar degeneration and Alzheimer's disease. Giraldo M; Lopera F; Siniard AL; Corneveaux JJ; Schrauwen I; Carvajal J; Muñoz C; Ramirez-Restrepo M; Gaiteri C; Myers AJ; Caselli RJ; Kosik KS; Reiman EM; Huentelman MJ Neurobiol Aging; 2013 Aug; 34(8):2077.e11-8. PubMed ID: 23582655 [TBL] [Abstract][Full Text] [Related]